Medicale focuses on the subdivisions of the optical optoelectronics and semiconductor industries. Its business covers the R&D, manufacturing and sales of precision optics, semiconductor acousto-optics, MEMS micro-nano circuits, semiconductor packaging and testing, and smart terminals.
Medicay said that with the continuous expansion of downstream application scenarios, the company urgently needs to further expand its product matrix and production capacity layout, accelerate market development, consolidate and expand market share, improve operating levels, and achieve sustained growth.
Specifically, MEMSThe planned investment in the device optical system manufacturing project is 474 million yuan, of which 300 million yuan of raised funds is planned to be used. The project focuses on expanding the production capacity of Micro LED chips and other MEMS devices. At the same time, the project will improve the production capacity of Micro LED chips and other MEMS devices to accurately respond to the needs of downstream customers for large-scale delivery. The project will also accelerate the market verification and iteration process of MEMS devices including Micro LED chips, and enrich the product service matrix.
Medicay stated that this project is deeply in line with the rapid growth trend of global MEMS optical devices.trend, AR/VR, vehicle-mounted display and other downstream application scenarios continue to expand, providing a solid market foundation for production capacity digestion.
In the field of Micro LED, some of Medica's downstream customers' products have covered AR glasses, automotive head-up displays, micro-projection, 3D Printing, sports optical instruments, light field display and other fields; other major customers have also completed product design and finalization and entered the key verification stage. Some customers have entered small batch trial production, which will provide strong support for the company's performance in the short term.
In the medium to long term, the company can expect an increase in future orders. Some downstream customers in the field of other MEMS devices (uncooled infrared chips) are well-known companies in this segment, with considerable production scale. Through in-depth cooperation with customers, the company has natural advantages in order acquisition and new product applications.
The semiconductor process bonding prism industrialization project plans to invest 263 million yuan, of which 200 million yuan is planned to be invested using raised funds. The project products are mainly used in optical fields such as periscope telephoto lenses for mobile phones, which can significantly improve the optical zoom capabilities and imaging quality of mobile phone cameras.
The implementation of this project will expand the company's semiconductor process bonding prism production capacity, enhance the company's capabilities in the research, development, design and production of prism products for semiconductor processes, and rely on existing customer resources to quickly promote market verification, consolidate the company's leading advantage in the market, enrich the company's product line, and inject continuous power into the long-term growth of the company's business.
In addition, Medicay plans to use 200 million yuan to raise funds to supplement working capital, which will helpIn order to solve the company's demand for working capital in the process of business development and ensure the company's sustainable development.
ANNA